The Role of Gut Microbiota in Pediatric Obesity and Metabolic Disorders: Insights from a Comprehensive Review
Nutrients · 30.05.2025 · 17 (11) · 1883
DOI: 10.3390/nu17111883 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 30.05.2025. Verfasst von Ana Maria Koller und 2 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Gheorghe Marinescu Street No 38, 5401…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Pediatric Obesity, Metabolic Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pediatric obesity represents a multifactorial condition in which gut microbiota dysbiosis, low-grade systemic inflammation, and metabolic dysfunction are intricately connected.
Objectives
This systematic review sought to evaluate and integrate current findings regarding the interactions between gut microbial composition, dietary influences, inflammatory status, and metabolic outcomes in obese pediatric populations.
Methods
A comprehensive search of PubMed, Scopus, and Web of Science databases was conducted for studies published from January 2010 onward. Eligible studies comprised randomized controlled trials, and cohort, cross-sectional, and longitudinal designs involving individuals aged ≤18 years. Study quality was appraised using the NIH Study Quality Assessment Tool.
Results
Sixteen studies fulfilled the inclusion criteria. Dysbiosis was consistently observed among obese children, characterized by alterations in microbial diversity and abundance associated with increased inflammation and adverse metabolic profiles. Dietary interventions, notably symbiotic supplementation and adherence to Mediterranean diet patterns, were associated with favorable modulation of gut microbiota and inflammatory parameters. The majority of studies demonstrated high methodological quality, although minor observational limitations were noted.
Conclusions
Gut microbiota dysregulation plays a central role in the development of metabolic and inflammatory complications associated with pediatric obesity. Although dietary and microbiota-modifying strategies show therapeutic promise, their effectiveness must be substantiated through robust, long-term studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Gheorghe Marinescu Street No 38, 540136 Targu Mures, Romania.
- Department of Pediatrics 3, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Gheorghe Marinescu Street No 38, 540136 Targu Mures, Romania.
- Department of Pediatrics 1, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Gheorghe Marinescu Street No 38, 540136 Targu Mures, Romania.
ORCID-Profile: Ana Maria Koller, Maria Oana Săsăran, Cristina Oana Mărginean
Zitieren
APA
Koller, A. M., Săsăran, M. O., & Mărginean, C. O. (2025). The Role of Gut Microbiota in Pediatric Obesity and Metabolic Disorders: Insights from a Comprehensive Review. Nutrients, 17(11), 1883. https://doi.org/10.3390/nu17111883
Vancouver
Koller AM, Săsăran MO, Mărginean CO. The Role of Gut Microbiota in Pediatric Obesity and Metabolic Disorders: Insights from a Comprehensive Review. Nutrients. 2025;17(11):1883. doi:10.3390/nu17111883
BibTeX
@article{Koller2025,
author = {Koller, Ana Maria and Săsăran, Maria Oana and Mărginean, Cristina Oana},
title = {The Role of Gut Microbiota in Pediatric Obesity and Metabolic Disorders: Insights from a Comprehensive Review},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {11},
pages = {1883},
doi = {10.3390/nu17111883}
}
EUVIMED